Successful treatment of MYCN amplified, progressive stage 4S neuroblastoma in a neonate with hepatic artery embolization in addition to multimodality treatment

Pediatr Blood Cancer. 2006 Feb;46(2):253-7. doi: 10.1002/pbc.20407.

Abstract

Stage 4S metastatic neuroblastoma (NB) has a favorable prognosis due to a high rate of spontaneous regression. Young infants risk lethal complications arising from hepatomegaly, which can develop rapidly despite treatment. MYCN oncogene amplification confers a significantly worse prognosis. We describe a 4-week-old neonate with MYCN-amplified stage 4S NB complicated by gross hepatomegaly causing rapidly progressive respiratory, hepatic, and renal failure. The child remains in remission 3 years after hepatic artery embolization, radiotherapy, standard, and high-dose chemotherapy. Embolization of the hepatic artery, with classical treatment, is feasible and safe at this age and may contribute substantially to the management of high-risk patients.

Publication types

  • Case Reports

MeSH terms

  • Combined Modality Therapy
  • Embolization, Therapeutic*
  • Gene Amplification*
  • Hepatic Artery* / diagnostic imaging
  • Hepatomegaly / diagnostic imaging
  • Hepatomegaly / genetics
  • Hepatomegaly / therapy
  • Humans
  • Infant, Newborn
  • N-Myc Proto-Oncogene Protein
  • Neuroblastoma / diagnostic imaging
  • Neuroblastoma / genetics
  • Neuroblastoma / therapy*
  • Nuclear Proteins / genetics*
  • Oncogene Proteins / genetics*
  • Radiography

Substances

  • MYCN protein, human
  • N-Myc Proto-Oncogene Protein
  • Nuclear Proteins
  • Oncogene Proteins